1H-nuclear magnetic resonance-based metabonomic analysis of brain in rhesus monkeys with morphine treatment and withdrawal intervention

Journal of Neuroscience Research

Volumn 90, Issue 11, 2012, Pages 2154-2162

  Deng, Yi ^a   Bu, Qian ^a   Hu, Zhengtao ^a   Deng, Pengchi ^b   Yan, Guangyan ^a   Duan, Jiachuan ^a   Hu, Chunyan ^a   Zhou, Jiaqing ^a   Shao, Xue ^a   Zhao, Jinxuan ^a   Li, Yan ^a   Zhu, Ruiming ^a   Zhao, Yinglan ^a   Cen, Xiaobo ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Clonidine; Metabonomic; Methadone; Morphine; Primate

Indexed keywords

4 AMINOBUTYRIC ACID; ACETYLCYSTEINE; CLONIDINE; CREATINE; GLUTAMIC ACID; GLUTATHIONE; HOMOCYSTEIC ACID; HOMOCYSTEINE; INOSITOL; LACTIC ACID; METHADONE; METHIONINE; MORPHINE; N ACETYLASPARTIC ACID; NEUROTRANSMITTER; PHOSPHORYLCHOLINE; SUCCINIC SEMIALDEHYDE; TAURINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN METABOLISM; BRAIN REGION; CELL MEMBRANE; CONTROLLED STUDY; ENERGY METABOLISM; FEMALE; HIPPOCAMPUS; MALE; MORPHINE ADDICTION; NEUROBIOLOGY; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RHESUS MONKEY; WITHDRAWAL SYNDROME;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; FEMALE; MACACA MULATTA; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METABOLOMICS; METHADONE; MORPHINE; MORPHINE DEPENDENCE; NARCOTICS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84866020474     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.23109     Document Type: Article

References (41)

1. Abdelhamid EE, Sultana M, Portoghese P, Takemori A. 1991. Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice. J Pharmacol Exp Ther 258: 299-303.
2. Andrus PK, Fleck TJ, Gurney ME, Hall ED. 1998. Protein oxidative damage in a transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem 71: 2041-2048.
3. Baslow MH. 2003. N-acetylaspartate in the vertebrate brain: metabolism and function. Neurochem Res 28: 941-953.
4. Bothwell J, Rae C, Dixon R, Styles P, Bhakoo K. 2001. Hypo-osmotic swelling-activated release of organic osmolytes in brain slices: implications for brain oedema in vivo. J Neurochem 77: 1632-1640.
5. 1H-NMR-based metabonomics. Nat Med 8: 1439-1445.
6. Brown JM, Yamamoto BK. 2003. Effects of amphetamines on mitochondrial function: role of free radicals and oxidative stress. Pharmacol Ther 99: 45-53.
7. Carroll IR, Angst MS, Clark JD. 2004. Management of perioperative pain in patients chronically consuming opioids. Region Anesth Pain Med 29: 576-591.
8. Clarke D, Sokoloff L. 1999. Circulation and energy metabolism of the brain. Basic Neurochem 6: 637-669.
9. De Vries TJ, Shippenberg TS. 2002. Neural systems underlying opiate addiction. J Neurosci 22: 3321.
10. Dringen R. 2000. Metabolism and functions of glutathione in brain. Prog Neurobiol 62: 649-671.
11. El Idrissi A. 2008. Taurine increases mitochondrial buffering of calcium: role in neuroprotection. Amino Acids 34: 321-328.
12. Eriksson L, Johansson E, Kettaneh-Wold N, et al. 2006. Multi- and megavariate data analysis: part 1 basic principles and applications. Umeå: Umetrics AB.
13. Everitt BJ, Dickinson A, Robbins TW. 2001. The neuropsychological basis of addictive behaviour. Brain Res Rev 36: 129-138.
14. Fitsanakis VA, Au C, Erikson KM, Aschner M. 2006. The effects of manganese on glutamate, dopamine and gamma-aminobutyric acid regulation. Neurochem Int 48: 426-433.
15. Gao HC, Xiang Y, Sun NL, Zhu H, Wang YQ, Liu ML, Ma YY, Lei H. 2007. Metabolic changes in rat prefrontal cortex and hippocampus induced by chronic morphine treatment studied ex vivo by high resolution H-1 NMR spectroscopy. Neurochem Int 50: 386-394.
16. Giove F, Mangia S, Bianciardi M, Garreffa G, Di Salle F, Morrone R, Maraviglia B. 2003. The physiology and metabolism of neuronal activation: in vivo studies by NMR and other methods. Magn Reson Imag 21: 1283-1293.
17. 2-adrenergic agonists for the management of opioid withdrawal. Cochrane Database Syst Rev (Online): CD002024.
18. Hong H, Lu Y, Ji ZN, Liu GQ. 2006. Up-regulation of P-glycoprotein expression by glutathione depletion-induced oxidative stress in rat brain microvessel endothelial cells. J Neurochem 98: 1465-1473.
19. Isaacks RE, Bender AS, Kim CY, Prieto NM, Norenberg MD. 1994. Osmotic regulation of myo-inositol uptake in primary astrocyte cultures. Neurochem Res 19: 331-338.
20. A antagonists-induced seizures in morphine dependent rats: possible mechanisms in seizure propensity. Pharmacol Biochem Behav (in press).
21. 18F]cyclofoxy in long-term, methadone-treated former heroin addicts. J Pharmacol Exp Ther 295: 1070-1076.
22. Kuriyama K, Yoneda Y. 1978. Morphine induced alterations of γ-aminobutyric acid and taurine contents and l-glutamate decar ylase activity in rat spinal cord and thalamus: possible correlates with analgesic action of morphine. Brain Res 148: 163-179.
23. Leri F, Tremblay A, Sorge RE, Stewart J. 2004. Methadone maintenance reduces heroin-and cocaine-induced relapse without affecting stress-induced relapse in a rodent model of poly-drug use. Neuropsychopharmacol 29: 1312-1320.
24. 1H NMR spectroscopy: N-acetyl-l-aspartate, creatine and choline. NMR Biomed 4: 47-52.
25. Nicholson JK, Connelly J, Lindon JC, Holmes E. 2002. Metabonomics: a platform for studying drug toxicity and gene function. Nat Rev Drug Discov 1: 153-162.
26. + evoked glutamate release from rat cerebrocortical slices. Neurosci Lett 218: 79-82.
27. Patkar AA, Rozen S, Mannelli P, Matson W, Pae CU, Krishnan KR, Kaddurah-Daouk R. 2009. Alterations in tryptophan and purine metabolism in cocaine addiction: a metabolomic study. Psychopharmacology 206: 479-489.
28. Pushpakiran G, Mahalakshmi K, Anuradha C. 2004. Taurine restores ethanol-induced depletion of antioxidants and attenuates oxidative stress in rat tissues. Amino Acids 27: 91-96.
29. Saboory E, Derchansky M, Ismaili M, Jahromi SS, Brull R, Carlen PL, El Beheiry H. 2007. Mechanisms of morphine enhancement of spontaneous seizure activity. Anesth Analgesia 105: 1729-1735.
30. Schroeder H, Becker A, Grecksch G, Schroeder U, Hoellt V. 1998. The effect of pentylenetetrazol kindling on synaptic mechanisms of interacting glutamatergic and opioid system in the hippocampus of rats. Brain Res 811: 40-46.
31. Stotts AL, Dodrill CL, Kosten TR. 2009. Opioid dependence treatment: options in pharmacotherapy. Expert Opin Pharmacother 10: 1727-1740.
32. +/myo-inositol contransport in rat cortical astrocytes. Glia 12: 35-43.
33. 1H NMR spectroscopy. J Proteome Res 5: 483-492.
34. Tsuji M, Nakagawa Y, Ishibashi Y, Yoshii T, Takashima T, Shimada M, Suzuki T. 1996. Activation of ventral tegmental GABAB receptors inhibits morphine-induced place preference in rats. Eur J Pharmacol 313: 169-173.
35. Vaughan C, Ingram S, Connor M, Christie M. 1997. How opioids inhibit GABA-mediated neurotransmission. Nature 390: 611-614.
36. Veech RL. 1991. The metabolism of lactate. NMR Biomed 4: 53-58.
37. Walls AB, Nilsen LH, Eyjolfsson EM, Vestergaard HT, Hansen SL, Schousboe A, Sonnewald U, Waagepetersen HS. 2010. GAD65 is essential for synthesis of GABA destined for tonic inhibition regulating epileptiform activity. J Neurochem 115: 1398-1408.
38. Werz MA, MacDonald RL. 1982. Opiate alkaloids antagonize postsynaptic glycine and GABA responses: correlation with convulsant action. Brain Res 236: 107-119.
39. Westerink B, Kwint H, DeVries J. 1996. The pharmacology of mesolimbic dopamine neurons: a dual-probe microdialysis study in the ventral tegmental area and nucleus accumbens of the rat brain. J Neurosci 16: 2605-2611.
40. Yang SO, Hyun SH, Kim SH, Kim H, Lee J, Whang WK, Lee MW, Choi HK. 2010. Differentiation of roots of Glycyrrhiza species by H nuclear magnetic resonance spectroscopy and multivariate statistical analysis. Bull Korean Chem Soc 31: 825-828.
41. Zhang X, Liu H, Wu J, Liu M, Wang Y. 2009. Metabonomic alterations in hippocampus, temporal and prefrontal cortex with age in rats. Neurochem Int 54: 481-487.